Category Press Releases

VION Biosciences Acquires Echelon Biosciences, Specialist in Lipids and Nanoparticles

VION Biosciences, a company specializing in life science reagents, has acquired Echelon Biosciences, a key supplier of lipid-based materials. This acquisition is the second under VION Biosciences LLC, the roll-up platform from Iron Path Capital led by Mark Thornton. Echelon,…

Read MoreVION Biosciences Acquires Echelon Biosciences, Specialist in Lipids and Nanoparticles

Brenntag Acquires PIC and PharmaSpecial, Expanding Pharma and Personal Care Presence in Brazil

Brenntag, the global leader in chemical and ingredient distribution, has announced the acquisition of PIC Química e Farmacêutica Ltda. (PIC) and PharmaSpecial Especialidades Químicas e Farmacêuticas Ltda. (PharmaSpecial) in Brazil. This move significantly enhances Brenntag’s presence in the expanding Life…

Read MoreBrenntag Acquires PIC and PharmaSpecial, Expanding Pharma and Personal Care Presence in Brazil

Mueller Industries, Inc. Acquires Elkhart Products Corporation

Mueller Industries, Inc. (NYSE: MLI) has announced the acquisition of Elkhart Products Corporation (EPC), a U.S. manufacturer specializing in copper solder fittings. EPC operates two manufacturing facilities located in Elkhart, Indiana, and Fayetteville, Arkansas. Mueller’s CEO, Greg Christopher, commented, “The…

Read MoreMueller Industries, Inc. Acquires Elkhart Products Corporation

MIP Discovery Rebrands as Tozaro, Shifting Focus to Cell and Gene Therapy Viral Vector Analytics and Purification

MIP Discovery has announced its rebranding to Tozaro, marking its transition to a leading innovator in the cell and gene therapy (CGT) bioprocessing sector. This change comes in the wake of significant growth, including a strategic refocusing on enhancing downstream…

Read MoreMIP Discovery Rebrands as Tozaro, Shifting Focus to Cell and Gene Therapy Viral Vector Analytics and Purification

908 Devices Announces Q2 2024 Financial Results and Confirms 2024 Revenue Forecast

908 Devices Inc. (Nasdaq: MASS), a leader in handheld and desktop devices for chemical analysis, announced its financial results for the quarter ending June 30, 2024. Kevin J. Knopp, CEO and Co-founder, highlighted the company’s strong performance, including the successful…

Read More908 Devices Announces Q2 2024 Financial Results and Confirms 2024 Revenue Forecast